NSC 153858
CAS: 35846-53-8
Rif. 3D-FM29496
1mg | Prezzo su richiesta | ||
2mg | Prezzo su richiesta | ||
5mg | Prezzo su richiesta | ||
10mg | Prezzo su richiesta |
Informazioni sul prodotto
- N-Acetyl-N-methyl-L-alanine [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8 ,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl esterMaytansine
- (2'R,3beta,4beta,6beta,7beta,9beta)-maytansine
- (3Beta,4Beta,6Beta,7Beta,9Beta)-Maytansine
- (4beta,11E,13E)-maytansine
- 4,24-Dioxa-9,22-diazatetracyclo[19.3.1.1<sup>10,14</sup>.0<sup>3,5</sup>]hexacosane, maytansine deriv.
- <span class="text-smallcaps">L</span>-Alanine, N-acetyl-N-methyl-, 11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1<sup>10,14</sup>.0<sup>3,5</sup>]hexacosa-10,12,14(26),16,18-pentaen-6-yl ester, [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-
- Brn 5417399
- L-Alanine, N-acetyl-N-methyl-, 11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo(19.3.1.110,14.03,5)hexacosa-10,12,14(26),16,18-pentaen-6-yl ester, (1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*))-
- Maitansina
- Maitansina [INN-Spanish]
- Vedi altri sinonimi
- Maitansinum
- Maitansinum [INN-Latin]
- Maysanine
- Maytansin
- Maytansine
- Maytansine [USAN]
- N-Acetyl-N-methyl-<span class="text-smallcaps">L</span>-alanine [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1<sup>10,14</sup>.0<sup>3,5</sup>]hexacosa-10,12,14(26),16,18-pentaen-6-yl ester
- N-Acetyl-N-methyl-L-alanine(1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*))-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethy-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo(19.3.1.1(sup 10,14).0(sup 3,5))hexacosa-10,12,14(26),16,18-pentaen-6-yl ester
- Nsc 153858
- Unii-14083Fr882
NSC 153858 is a conjugate of the antibody murine sarcoma virus (MSV) with maytansine. It has been shown to be effective against breast cancer and other cancers. The MSV-maytansine conjugate specifically binds to low-density lipoprotein receptors on tumor cells, which are not present in normal cells. This results in an antitumor response that is more specific for tumor cells than traditional chemotherapy drugs such as trastuzumab, which can have severe side effects. NSC 153858 has been found to have minimal toxicity in animal studies and has shown promising antitumor activity in vitro against hl-60 cells and breast cancer cell lines.
Proprietà chimiche
Richiesta tecnica su: 3D-FM29496 NSC 153858
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.